IMAAVY

NIPOCALIMAB · Janssen Biotech, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for IMAAVY, covering 2025-04-29 to 2026-08-24. Get the full timeline:

Most recent: FDA Approved: IMAAVY — Supplemental Application (Janssen Biotech, Inc.)